mead cohen berger shevtsova garfinkle michta grygiel blankenhorn
This is your free article this month. A quality publication is not cheap to produce.
Subscribe today and support The American Interest—only $2.99/month!
Already a subscriber? Log in to make this banner go away.
Published on: February 13, 2015
To Your Health
Precise But (Not Yet) Personal

President Obama’s new initiative to fund genetic sequencing could be a powerful tool for good in improving U.S. health care—but only if the medical establishment welcomes it.

Ralph Snyderman, M.D., is chancellor emeritus of Duke University and former president and CEO of the Duke University Health System and director of Duke’s Center for Research on Personalized Health Care.
show comments
© The American Interest LLC 2005-2016 About Us Masthead Submissions Advertise Customer Service